Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
A Bayesian Phase I/II Trial Design for Immunotherapy
Suyu Liu
, Beibei Guo,
Ying Yuan
Biostatistics
Research output
:
Contribution to journal
›
Article
›
peer-review
32
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A Bayesian Phase I/II Trial Design for Immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Mathematics
Immunotherapy
100%
Dose
70%
Immune Response
50%
Design
40%
Toxicity
33%
Efficacy
27%
Cancer
26%
Target
22%
Dose Finding
18%
Chemotherapy
17%
Immune System
17%
Operating Characteristics
16%
Latent Variables
14%
Marginal Distribution
13%
Trade-offs
13%
Model
12%
Simulation Study
9%
Distinct
9%
Demonstrate
7%
Estimate
5%
Business & Economics
Toxicity
60%
Cancer
42%
Efficacy
40%
Chemotherapy
28%
Latent Variables
23%
Simulation Study
20%
Trade-offs
15%